Treating Alzheimer’s in the Era of Biomarkers

About the episode:

In this episode, Mayo Clinic Alzheimer’s expert Dr. Ronald Petersen explores advances in recognizing and preventing Alzheimer's disease, highlighting the disease’s increasing prevalence and new efforts to change how it is managed. He emphasizes the importance of early detection and lays out the latest developments in biomarker research. Dr. Petersen discusses mild cognitive impairment (MCI) as a crucial stage in understanding Alzheimer’s progression. The episode also examines emerging technologies in diagnosis and treatment, and underscores the shift toward patient-centered care and the need for public education.

About the series:

Atria’s Vanguard Symposia is a lecture series where some of the world’s most compelling researchers translate leading-edge science into medicine. In each episode, top experts share breakthrough science about preventive health care, dive deep into headline-grabbing topics, and take you beyond the buzzwords to explain the latest in longevity science. Our show will arm you with practical information and the tools of discernment to cut through the hype and understand what matters most.

Atria Health and Research Institute aims to accelerate a global shift from reactive sick care to proactive, preventive health care. We work at the forefront of science and technology and we believe a collaborative approach to modern medicine can extend healthy life for all.